Meeting News
-
Closing Plenary Will Focus on the Importance of Advancing Patient Advocacy
Experts will focus on overcoming barriers in patient advocacy on a global basis and enhancing the patient-physician partnership.
-
IASLC Lectureships Focus on Contributions of Leaders in Thoracic Oncology
Tuesday morning, nine expert clinicians and researchers in the field will give award lectures in honor of their contributions to the treatment of lung cancer.
-
Session to Report Results of IASLC’s First Diversity, Equity, and Inclusion Survey
Drs. Narjust Florez and Cecilia Pompili will co-chair the session, which will also include tips for improving inclusion in clinical trials, creating a mutually respective work environment, and more.
-
IASLC Award Recognizes Importance of Teamwork in Cancer Care
The association’s most prestigious award was presented to five multidisciplinary teams from around the world during the IASLC Award Ceremony.
-
Don’t Miss Your Last Chance to Visit the Exhibit Hall
From seeing the latest advances in thoracic oncology to connecting with colleagues in the Membership Lounge, you can do it all in the Exhibit Hall.
-
Order Your Copy of the IASLC 50th Anniversary History Book Today
Edited by lung cancer legends Drs. Fred R. Hirsch and Paul A. Bunn, the book explores the many advances in thoracic oncology treatment throughout the past five decades.
-
HARMONi-2 Study Findings May Reshape the Therapeutic Paradigm of Frontline Driver Mutation-Negative Advanced NSCLC
First-line treatment with the novel bispecific antibody ivonescimab in the phase III HARMONi-2 trial improved PFS in patients with advanced NSCLC compared to pembrolizumab.
-
NeoCOAST-2 Shows Pathologic Response Benefit for Perioperative Durvalumab + ADC + Chemotherapy Combination
However, investigator Dr. Tina Cascone said that the findings of this first global phase II study of a neoadjuvant ADC must be interpreted with caution given the trial’s small sample size.
-
Plenary Session Will Unveil Impact of Non-Tobacco Factors in Lung Cancer Risk
Presentations will look beyond tobacco to address how exposure to other environmental hazards may play a role in the development of lung cancer.
-
Lung Cancer Beyond Smoking: Outdoor Air Pollution and Lung Cancer
Dr. Joan H. Schiller will discuss the impact the environment has on cancer care and outcomes.
View ILCN Archives
Provider Resources